Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIPONIMOD vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIPONIMOD vs SITAGLIPTIN: Safety Overview

Metric SIPONIMOD SITAGLIPTIN
Total FAERS Reports 8,581 19,904
Deaths Reported 196 2,412
Death Rate 2.3% 12.1%
Hospitalizations 1,396 6,668
Average Patient Age 53.8 yrs 67.3 yrs
% Female Patients 74.4% 52.3%
FDA Approval Date Apr 22, 2025 Dec 30, 2025
Manufacturer Novartis Pharmaceuticals Corporation A-S Medication Solutions
Route ORAL ORAL
Marketing Status Prescription Prescription